Table 2.

Response, progression, and mortality rates during micafungin treatment (FAS [n = 2467])

Comprehensive assessment of effectiveness, n (%); 95% CIa
Complete response	425 (17.2); 15.7–18.7
Partial response	1074 (43.5); 41.6–45.5
Stable response	473 (19.2); 17.6–20.7
Progression of disease	330 (13.4); 12.0–14.7
Death	165 (6.7); 5.7–7.7
Evaluation of overall success rate of patients at the end of treatment, n (%), 95% CI
Failure	968 (39.2); 37.3–41.2
Response	1499 (60.8); 58.8–62.7

CI confidence interval, FAS full analysis set

^aAsymptotic 95% CIs of the percentage response rate calculated